AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

21 recruiting trials

for Relapsed Advanced Lymphomas

A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor NCT06615193Phase 18 sites๐Ÿ“ Zhengzhou๐Ÿ“ Suzhou๐Ÿ“ Suzhou Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. ยท Tests: HDM2005 Evaluate the Safety and Clinical Activity of HH2853 NCT04390737Phase 1, Phase 225 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Rochester Haihe Biopharma Co., Ltd. ยท Tests: HH2853 Tablets A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma NCT05341557Phase 14 sites๐Ÿ“ Chaoyang๐Ÿ“ Cangzhou๐Ÿ“ Tianjin Betta Pharmaceuticals Co., Ltd. ยท Tests: BPI-371153 Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors NCT06132503Phase 11 site๐Ÿ“ West Valley City Lantern Pharma Inc. ยท Tests: LP-284 Combination of CAR-DC Vaccine and ICIs in Malignant Tumors NCT05631886Phase 11 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide, anti-PD-1 antibody, Anti-CTLA4 Monoclonal Antibody Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas NCT05956041Phase 21 site๐Ÿ“ Ann Arbor University of Michigan Rogel Cancer Center ยท Tests: Pembrolizumab, Mogamulizumab Immunotherapy in Lymphoma NCT06796517n/a2 sites๐Ÿ“ Seoul๐Ÿ“ Seoul Sung-Soo Park ยท Tests: CAR-T Therapy, Bispecific antibody, Antibody-Drug Conjugate, Monoclonal antibody, Proteasome Inhibitor Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma NCT06445517Phase 14 sites๐Ÿ“ Beijing๐Ÿ“ Nanchang๐Ÿ“ Shanghai InSilico Medicine Hong Kong Limited ยท Tests: ISM8207 Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma NCT06755450Phase 119 sites๐Ÿ“ Vadodara๐Ÿ“ Jhajjar๐Ÿ“ Bangalore Aurigene Discovery Technologies Limited ยท Tests: AUR112 A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. NCT06393738Phase 121 sites๐Ÿ“ New Haven๐Ÿ“ Miami๐Ÿ“ Detroit Arvinas Inc. ยท Tests: ARV-393, Glofitamab Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma NCT06376721Phase 1, Phase 21 site๐Ÿ“ Beijing Beijing Tongren Hospital ยท Tests: Linperlisib, Camrelizumab, Pegaspargase, Dexamethasone A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPฮฑ-CD47 Pathway, in Solid or Hematological Tumors NCT05892718Phase 18 sites๐Ÿ“ Port Saint Lucie๐Ÿ“ Huntersville๐Ÿ“ Greenville FBD Biologics Limited ยท Tests: HCB101 A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer NCT06678659Phase 1, Phase 27 sites๐Ÿ“ Duarte๐Ÿ“ Santa Monica๐Ÿ“ Cleveland Recursion Pharmaceuticals Inc. ยท Tests: REC-1245 An Engineered Sirpฮฑ Fused to Anti-Pd-L1 And Tgf-ฮฒ Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors NCT06487624Phase 17 sites๐Ÿ“ Greenville๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou FBD Biologics Limited ยท Tests: HCB301 Study of JMBI-001 in Patients With MYC-Positive Advanced Cancers NCT07864701Phase 1, Phase 21 site๐Ÿ“ Beijing Chengdu Anticancer Bioscience, Ltd. ยท Tests: JMBI-001 Tablets A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) NCT02332668Phase 1, Phase 216 sites๐Ÿ“ Aurora๐Ÿ“ Chicago๐Ÿ“ Boston Merck Sharp & Dohme LLC ยท Tests: Pembrolizumab JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma NCT07603479Phase 11 site๐Ÿ“ Beijing Jecho Biopharmaceuticals Co., Ltd. ยท Tests: JL19001, subcutaneous injection, 1 ฮผg/kg, JL19001, subcutaneous injection, 5 ฮผg/kg, JL19001, subcutaneous injection,10 โ€ฆ Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies NCT06034275Phase 15 sites๐Ÿ“ Birmingham๐Ÿ“ Cincinnati๐Ÿ“ Nashville Vincerx Pharma, Inc. ยท Tests: VIP943 (QW), VIP943 (BIW) IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers NCT06119685Phase 1, Phase 212 sites๐Ÿ“ Los Angeles๐Ÿ“ Lake Mary๐Ÿ“ Atlanta Indapta Therapeutics, INC. ยท Tests: IDP-023, Rituximab, Daratumumab, Interleukin-2, Cyclophosphamide A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1) NCT05984147Phase 127 sites๐Ÿ“ Visakhapatnam๐Ÿ“ Chandigarh๐Ÿ“ Ahmedabad Aurigene Discovery Technologies Limited ยท Tests: AUR108 Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors NCT07410494Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: EB-SELECT Single-Target CAR-NK Cells, Dual-Target Antigen-Selected CAR-NK
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy